Jitendra Wadhane

All filings by Jitendra Wadhane on record concern Pyxis Oncology, Inc. Over a trading history stretching from 24 March 2023 to 24 March 2026, the count stands at 8 filings.

No open-market sale appears; the market trades are 3 purchases worth €17k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants.

In size, the median ticket on the buying side is €4,450. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -6.5%. These figures describe past trades and do not predict future prices.

The record was last updated on 25 March 2026 with a share grant in Pyxis Oncology, Inc. The last purchase on record was published on 27 September 2023, which is 1,117 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.